Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol with or without sufentanil for painless bronchoscopy anesthesia recovery
ChiCTR2300071785Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol and sufentanil in procedural sedation and analgesia (PSA) (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Grading of anesthetic effects, Awakening time and 1 more. Started May 2023; status: recruiting.
02
Drugs
ciprofolsufentanil
03
Conditions
procedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2300071785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071785.